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Abstract
Background: Lung cancer is one of the most common cancers worldwide and has the highest
cancer-related mortality rate. Epidemiologic studies, including the Environment and Genetics in
Lung Cancer Etiology (EAGLE) study, have reported that frequent consumption of quercetinrich foods is inversely associated with lung cancer incidence. Although experimental studies
suggest that quercetin intake might modulate microRNA (miR) expression, this mechanism has
not been fully examined. We investigated this hypothesis in lung carcinogenesis using EAGLE
lung cancer tissues.
Methods: miR expression data were measured by a custom-made array in formalin-fixed
paraffin-embedded tissue samples from 264 lung cancer cases (144 adenocarcinomas and 120
squamous cell carcinomas). Intake of quercetin-rich foods was derived from a food-frequency
questionnaire. Individuals were categorized into sex-specific tertiles of quercetin-rich food
intake. In individual-miR-based analyses, we compared the expression of miRs (n=198) between
lung cancer cases consuming high-versus-low quercetin-rich food intake using multivariate
ANOVA tests. In family-miR-based analyses, we grouped individual miRs into biologically
functional families and conducted analyses using Functional Class Scoring (FCS). We
accounted for multiple testing using 10,000 global permutations (significance at p-valueglobal
<0.10). All analyses were conducted separately by histology (adenocarcinoma and squamous
cell carcinoma) and by smoking status (former and current smokers). Results: Family-based
analyses showed that a quercetin-rich diet strongly differentiated miR expression profiles of the
let-7 family among adenocarcinomas (p-valueFCS<0.001). Other significantly differentiated miR
families included miR-146, miR-26, and miR-17 (p-valuesFCS<0.05). In the individual-based
analyses, we found that among former and current smokers with adenocarcinoma, 33 miRs were
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observed to be differentiated between highest and lowest quercetin-rich consumers (23 expected
by chance; p-valueglobal = 0.047). Additionally, we identified 25 miRs to be differentially
expressed among former smokers with adenocarcinoma (22 expected by chance; pvalueglobal=0.076). Conclusions: We observed differential expression of key biologically
functional miRNAs between high-versus-low consumers of quercetin-rich foods in
adenocarcinoma cases. Our findings, the first of this kind, warrant confirmation from larger
studies.
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Introduction
Quercetin is a polyphenol ubiquitously present in certain fruits (e.g., apples and grapes)
and vegetables (e.g., onions, kale, broccoli, lettuce, and tomatoes) and has been found to possess
anticarcinogenic properties 1. We2 and others 3-5 previously observed that a quercetin-rich diet
was associated with lower risk of lung cancer. Quercetin and quercetin-rich foods may prevent
carcinogenesis via several mechanisms 6, including free radical scavenging, pro-apoptotic and
anti-proliferation pathway mediation, modification of anti-inflammatory responses, and
activation of detoxifying Phase II enzymes 7-10.
New findings suggested that polyphenol compounds like quercetin are more likely to
interact with cellular signaling cascades that regulate transcription factors.11 More specifically,
in vitro12, 13 and in vivo14 studies showed that they modulate a wide range of miR expressions and
may consequently influence carcinogenesis. 13, 14 MiRs are short, non-coding, single-stranded
RNAs involved in gene expression of multiple target mRNAs.15 Misregulated miRs have been
implicated in many cancers where they act to promote overexpression of oncogenes and
underexpression of tumor suppressor genes.16 For example, the let-7 class of miRs function as
tumor suppressors by repressing cell proliferation and regulating both RAS and c-myc
oncogenes.17 In lung cancer, we previously showed that the let-7 family is differentially
expressed by histology and is associated with survival in the Environment And Genetics in Lung
Cancer Etiology (EAGLE) study.15
Polyphenolic compounds, including quercetin, have been shown to alter expression of
several cancer-related miRs, including the cancer-associated let-7 family.18-23 Quercetin
metabolites were observed to modulate miR-155 in murine macrophages18 and miR-146a in
colon cancer cells.21 Another polyphenol, Epigallocatechin has been shown to upregulate miR-
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16 in human hepatocellular cancer cells.23 Additionally, differential expression of the let-7
family and other miRs was observed in human hepatocellular cancer cells exposed to
Ellagitannin.22
The emerging evidence from in vitro and in vivo investigations provides biological
rationale to examine the influence of quercetin on miR expression in lung carcinogenesis in the
present epidemiologic study. As a follow-up study to our observation that a quercetin-rich diet
was inversely associated with lung cancer in EAGLE participants,24 we investigated the
influence of quercetin-rich food consumption on miR expression signatures in lung tissues of
lung cancer patients. Given the importance of let-7 in lung carcinogenesis and their association
with polyphenols, we specifically focused on several members of the let-7 family as a priori
candidates for quercetin modification. To our knowledge, this is the first mechanistic
investigation of this nature using human tissues in relation to dietary quercetin-rich food
consumption.

Materials and Methods
Study population
The present study is based on 144 adenocarcinoma (AD) and 120 squamous cell
carcinoma (SQ) subjects from the EAGLE case-control study. The EAGLE study design has
been previously described.25 Briefly, EAGLE is a population-based case-control study of lung
cancer conducted in the Lombardy region of Italy between 2002 and 2005
(http://dceg.cancer.gov/eagle). Confirmed, incident, lung cancer cases (N=2100) were recruited
from 13 hospitals that examined ~80% of all cases within the catchment area, which included 5
cities (Milan, Monza, Brescia, Pavia, and Varese), surrounding towns, and villages. The majority
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of cases (95%) were confirmed by pathology reports and the remaining cases by imaging and
documentation of clinical history. Histologic type was recorded for all cases.

miR expression data
We previously described the miR expression data from EAGLE.15 Briefly, the miR
expression data were derived from formalin-fixed paraffin-embedded (FFPE) tissue samples in
144 lung adenocarcinoma and 120 squamous cell carcinoma cases from EAGLE. The 264
individuals included in the current study were a subgroup with both dietary quercetin
information and miR expression data. The miRs were analyzed using a custom-made, twochannel oligo-array that included a total of 713 human, mammalian, and viral mature antisense
miRs standardized to one EBV cell line. Individual miRs with low overall signal intensity (<100)
or low signal/noise ratio were excluded. Of the 440 human miRs, a total of 198 miRs were
retained in the final analysis and are reported in Supplemental Table S1.

Epidemiologic and Quercetin-rich food data
At baseline, epidemiologic data were collected using both a computer-assisted personal
interview and a self-administered questionnaire to address potential risk factors associated with
lung cancer, including comprehensive data on smoking exposure and dietary intake specific to
this Italian population.25 Dietary intake in the previous year was obtained from a selfadministered 58 item food frequency questionnaire (FFQ) where frequency of consumption was
designated using 11 possible response categories that ranged from ‘never’ to ‘2 or more times a
day’. Quercetin-rich food items (apples, grapes, onions, artichoke/fennel/celery, beans/chick
peas, apricots, plum, turnips, peppers, strawberries, tomatoes, and broccoli) in the FFQ were

11
identified based on data published in the United States Department of Agriculture on foodspecific quercetin content (>0.50 mg/100g).26 We created a summary measure of quercetin-rich
foods by adding the frequency of intake reported over one year for the individual food item.

Statistical analysis
Quercetin-rich food intake was divided into sex-specific tertiles based on the distribution
of the controls from the EAGLE study.2 We further defined highest and lowest consumers of
quercetin-rich foods to be those in the third and first tertile, respectively. We previously showed
that miR levels differed by histology in this population15 and miR expression was found to be
associated with smoking status;27 therefore, all our analyses were performed for smokingspecific (former and current smokers) and lung cancer subtype (adenocarcinoma and squamous
cell carcinoma). Although we examined the influence of quercetin-rich food intake on miR
expression in never smokers, the results were unstable and not reported due to too few
individuals (n=29).

Individual-miR-based analyses: We first compared the expression levels of 198 miRs between
highest (T3) and lowest (T1) quercetin-rich food consumers using multivariate ANOVA tests.
Models were adjusted for age (continuous), sex, body mass index (continuous), smoking
intensity (pack-years, continuous), consumption of non-quercetin-rich fruits and vegetables
(continuous), red/processed meats (continuous), and lifetime alcohol consumption (continuous).
Selection of covariates was based on factors that have been associated with either miR
expression or lung cancer risk. Individual food items comprised within the individual food
groups are described in Supplemental Table S2.
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To further address the issue of multiple comparisons we calculated a global p-value
(pglobal). For this calculation, we randomly permuted the highest and lowest classes of quercetin
intake 10,000X where the number of significant miRs from ANOVA testing was recorded (nP).
The global p-value is then defined as one plus the number of times in which np was at least as
large as the number of original significant miRs divided by10,000.

Family-miR-based analyses: We grouped each miR into known biological functional families
using MiRBase release 17.0 (http://microrna.sanger.ac.uk/). We first assembled miRs into
families based on unique ‘seed sequence’ (nucleotides 2-7 at the 5’end) and identified 21 miR
families (Supplemental Table S3). We then restricted our analyses to 9 miR families with at
least one miR identified at a p-value < 0.05 in the individual-miR-based analyses (Table 3). We
used Functional Class Scoring (FCS) to compare the expression profile of each miR family
between high-versus-low consumers of a quercetin-rich diet.
FCS computes p-values by assigning all miRs within a particular group (or family) an
aggregate raw score (the arithmetic mean of the negative natural logarithm of each p-value
obtained from miR analyses).28 This raw score was then compared to the score of randomly
derived groups of the same size through q repeated samplings (q=1,000). Each score was ordered
in ascending order to build an empirically derived score distribution. The FCS p-value was
determined as the fraction of randomly sampled groups having a higher score than the group
score of interest. For these analyses, we defined statistical significance at a p-valueFCS <0.05.
We further evaluated the statistical significance using the more conservative Bonferroni p-value
(0.05/9= 0.006).
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Permutations were performed in the statistical package R and we considered a permuted
pglobal < 0.10 to be statistically significant. All other analyses were performed using SAS,
version 9.2.

Results
In the present study, lung cancer cases had a mean age at diagnosis of 65 years. Table 1
presents the distribution of selected characteristics by tertiles of quercetin intake, separately for
adenocarcinoma and squamous cell carcinoma. Among ever smokers, highest (T3) consumers of
quercetin-rich foods smoked less and were more likely to be AD cases compared with low
consumers. Former smokers on average consumed more servings of quercetin-rich foods per day
than current smokers (1.65±0.88 vs. 1.29±0.79). Compared with AD cases, SQ cases tended to
be males, smoked more, and consumed more alcohol and meat across tertiles of quercetin intake.
Never smokers (n=29) were all AD except for one individual.

Individual- miR-based expression
We identified 16 miRs that were differentially expressed for AD (4 miRs) and SQ (12
miRs) cases (p-values < 0.05) between high-versus-low consumers of quercetin-rich foods
(Table 2). Likewise, 19 miRs were differentially expressed for former (12 miRs) and current (7
miRs) smokers (see Supplemental Table S4).
Table 3 presents analyses examining the association of quercetin-rich diet with miR
expression within histologic subtypes for former and current smokers separately. We identified
48 unique miRs that were differentially expressed between highest-vs-lowest quercetin-rich
consumers for all groups (p-value < 0.05, Table 3). These identified miRs have been shown to
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decrease tumor metastasis and invasion (miR-146a/b, -503, and -194), decrease cell proliferation
(miR-125a, -155, let-7 family, -302c, -195, -26a, -503, and -215), increase apoptosis (miR-125a,
-605, -26b, let-7g, -34a, -491, and -16), and target tumor suppressors (let-7 family , miR-125a, 183, -146a, -98, -19b, -106a, and -381).
Among former and current smokers with AD, 33 miRs were observed to be differentiated
between highest and lowest quercetin-rich consumers (23 expected by chance; p-valueglobal =
0.047, Table 3). For SQ cases, we identified 15 miRs (p-valueglobal > 0.10).
Quercetin-associated miR expression profiles appeared to be more prevalent among
former smokers with AD. In this group, we identified 25 miRs with a p-value < 0.05 (22
expected by chance; p-valueglobal = 0.076). The largest fold-change was observed for miR-26b, a
proapoptotic miR (fold-change = 2.00; p-value = 0.020). Notably, among the identified
significant miRs, all of the let-7 family members (let-7a, let-7b, let-7c, let-7d, let-7e, let-7f, let7g, let-7i, and miR-98) were associated with a quercetin-rich diet at a p-value ≤ 0.05. Moreover,
the majority of let-7 family members were up-regulated with increasing frequency of quercetin
intake (Figure 1).
In comparison to AD cases, far fewer miRs were identified at a p-value < 0.05 among SQ
cases. None of these groups were statistically significant when we calculated the global p-value
(p-valuesglobal > 0.10).

Family- miR-based expression
Table 4 presents the results examining the association of quercetin-rich foods with
families of miRs in smoking-specific analyses for AD and SQ cases. A quercetin-rich diet
appears to significantly differentiate miR expressions in former smokers with AD. Among this
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group, our data showed that the let-7 family was strongly differentiated by a quercetin-rich diet
(p-valueFCS < 0.001, Table 4) followed by miR-146 (p-valueFCS = 0.002), miR-26 (p-valueFCS =
0.010), and miR-17 (p-valueFCS = 0.031). Both the let 7 and the miR-146 families remained
significant after Bonferroni correction for multiple comparisons (0.05/9 = 0.006). We observed
no significant difference in miR expression for SQ cases and current smokers regardless of
histology.
Figure 1 graphically depicts the directionality of quercetin-associated miR expression of
let 7, miR-146, miR-26, and miR17 families with a quercetin-rich diet for formers smokers with
AD. In general, members of the let-7 family, miR-26 as well as miR-146b were up-regulated. In
contrast, the expression of miR-146a was downregulated.

Discussion
We previously observed higher consumption of quercetin-rich foods to be associated with
lower risk of lung cancer in a large population-based case-control study in Italy. The present
study tests the hypothesis that a quercetin-rich diet modulates the expression of miRs in human
lung tissues. In individual-miR-based analyses, we identified significant quercetin-associated
miR expression signatures for 48 unique miRs among AD and SQ cases who were former or
current smokers. The identified miRs have been shown to decrease cellular proliferation, reduce
tumor metastasis, and increase apoptosis in smoking-specific analyses (see Supplemental, Table
S5 for specific miRs). In family-miR-based analyses, we found that the large majority of
members of the let 7 family were upregulated among former smokers with AD who consumed a
higher intake of quercetin compared with low consumers (p-valueFCS < 0.001). We also
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observed similar family-based results for miR-146, miR-26, and miR-17 families (p-valueFCS <
0.05) in this group.
Due to its association with lung cancer, we specifically focused on the let-7 class of miRs
in relation to a quercetin-rich diet. In addition to being the most statistically significant result
based on FCS in the family-based analyses, the let-7 family remained significant after Bonferroni
correction at p-value < 0.006. Members of the let-7 family are known to function as tumor
suppressors in lung carcinoma by repressing NSCLC cell proliferation17, 29 and by negatively
regulating the RAS oncogene.30 Among the let-7 miRs in the present study, let-7a, a known
suppressor of k-RAS and c-Myc oncogenes,31 exhibited the largest fold change (fold-change =
1.46). Our data suggest a possible mechanism of quercetin-related tumor protection through the
increased expression of these key tumor suppressors.
We also observed differential quercetin-associated expression of the miR-17 family
(miR-20a, -20b, -106a, -106b, -17, and -93) in former smokers with AD. MiR-17 family belongs
to the oncogenic miR-17-92 cluster.32 Investigators have shown that the miR-17-92 cluster is
frequently overexpressed in lung cancer.33 Expression of miR-17 is associated with poorer
prognosis and cellular proliferation 34 while miR-106b targets p21 and subsequently promotes
cell cycle progression.35 Additionally, suppression of miR-20a induces apoptosis in lung
cancer.36 In our study, the majority of the miRs (67%) in miR-17 family were downregulated in
frequent consumers of quercetin-rich food among former smokers with AD.
Quercetin-rich food consumption also significantly differentiated miR-146 and miR-26
families in our study. Neither of these miR families has been extensively studied with respect to
lung carcinogenesis; however, both families have been associated with tumor development. In
lung alveolar epithelial cells, miR-146 was observed to negatively regulate pro-inflammatory
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chemokines.37 Additionally, miR-146a is one of two known miRs (miR-146a and -155) involved
in inflammatory signaling pathways and has been observed to be upregulated by quercetin in
experimental study.21 We corroborated this upregulation of miR-146a among higher consumers
of quercetin in the present study. One study showed that miR-155, a pro-inflammatory miR, was
downregulated with quercetin in murine cells.18 In lung carcinoma, miR-155 has often been seen
to be upregulated and to have prognostic impact.40 However, it has also been suggested to
function as a tumor suppressor by repressing cell proliferation.41 In the present study, miR-155
was not significant in the individual-miR-based analyses by histology and smoking status.
Both miR-26a and miR-26b exhibited the greatest fold change in our individual miRbased analyses (miR-26a, FC=1.78) and (miR-26b, FC=2.00). Our data suggest that a quercetinrich diet increases the expression of the miR-26 family, which has been shown to suppress cell
proliferation in nasopharyngeal carcinoma through G1 phase arrest and repression of c-Myc 38 as
well as induce apoptosis in breast cancer cells.39 Proapoptotic characteristics of miR-26 make
this particular group of miRs an important candidate for study in future research investigating
quercetin-mediated miR-targets.
We previously identified a miR expression profile that strongly differentiated
adenocarcinoma from squamous cell carcinoma with prognostic implications in EAGLE.15
Results from this present study showed consumption of quercetin-rich foods is associated with
differential miR expression by histology. In general, our data suggest that quercetin-rich foods
influenced miR expression in former smokers with AD, but not for SQ and current smokers. The
modest fold-change effect of dietary quercetin on miR expression might only be detectable in a
milieu that is less saturated by smoking exposure, as in former smokers and in AD which is less
associated with smoking than SQ.42 Furthermore, AD cases included in the present study on
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average smoked less intensely than SQ cases. The anti-carcinogenic capabilities associated with
dietary quercetin may be weakened in SQ cases by competing tobacco-related carcinogens.
To our knowledge, the present study is the only investigation of the association of dietary
quercetin with miR expression in lung tissues. In addition to having both dietary information
and miR expression data, this study included several variables that allowed tight control for
potential confounders. This richness of epidemiologic data coupled with epigenetic data from
human tissues permitted an integrative approach—making it possible to explore underlying
mechanisms that may explain the protective effect of quercetin and lung cancer risk.
Despite its uniqueness, the study had a limited sample size, which reduces statistical
precision, and explored a limited number of human miRs. Although the EAGLE questionnaire
assessed food consumption a year prior to the study, we cannot exclude the possibility that lung
cancer diagnosis had influenced the patients’ responses. However, this potential recall bias
should not have differentially affected the adenocarcinoma or squamous cell carcinoma cases
and could not explain the different association with quercetin by histologic type. Moreover, we
derived a quercetin-rich diet from food items available in the EAGLE’s FFQ and not measured
quercetin content directly; thus, we cannot rule out the contribution of other flavonoids or
nutrients that are found in those foods. Confirmation in a larger prospective study with both
dietary quercetin information and miR expression data is warranted.
In conclusion, we observed that a quercetin-rich diet is associated with differential
expression of key miRs in lung tissue within smoking specific histology groups. Notably,
expression of miRs in the let-7 family, a known tumor suppressor, was strongly associated with
frequent quercetin-rich food intake in the present study. Our findings provide potential insights
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into the observed inverse association between quercetin-rich food consumption and lung cancer
risk.
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a

Table 1. Selected characteristics by sex-specific tertile (T1-T3) of quercetin-rich food intake in EAGLE, separately for histologic subtypes
Adenocarcinoma

Subject characteristics
b

Quercetin-rich food intake , median (IQR)
Age, mean (SD)
Male, n (%)
BMI, mean (SD)

T1 (n=57)

T2 (n=47)

T3 (n=40)

0.79 (0.42)

1.56 (0.46)

2.45 (0.53)

62.58 + 9.03

64.58 + 8.21

65.57 + 8.55

Squamous Cell Carcinoma
p -value
0.22c
d

T1 (n=48)

T2 (n=42)

T3 (n=30)

0.71 (0.37)

1.47 (0.44)

2.53 (0.67)

68.48 + 7.09

69.02 + 6.30

66.37+ 8.62

0.29c

38 (66.67)

25 (53.19)

20 (50.0)

0.20

46 (95.83)

42 (100)

30 (100)

0.22d

24.42 + 3.76

25.59 + 3.98

24.42 + 3.17

0.21c

25.42 + 3.10

26.73 + 3.71

27.74 + 3.92

0.02 c

0.01 d

Smoking status (%)

0.08d

never

4 (7.02)

16 (34.04)

7 (17.50)

0

1 (2.38)

0

former

22 (38.60)

12 (25.53)

22 (55.0)

18 (37.50)

20 (47.62)

20 (66.67)

current
Pack-years, median (IQR)

p -value

31 (54.39)

19 (40.43)

11 (27.50)

40.0 (24.0)

34.5 (32.0)

33.0 (28.0)

30 (62.50)

21 (50.0)

10 (33.33)

54.0 (28.25)

46.25 (21.70)

42.50 (33.0)

0.63

0.22e

1.01 (0.43)

2.03 (0.79)

2.46 (1.93)

<0.01 e

0.95 (0.51)

1.68 (0.94)

2.61 (1.83)

<0.01 e

e

1.03 (0.89)

1.55 (0.69)

3.00 (1.37)

<0.01 e

e

Intake
Vegetables b,fmedian (IQR)
b,g

Fruits , median (IQR)

0.96 (0.82)

1.78 (1.28)

2.80 (1.40)

<0.01

Meats b,h , median (IQR)

0.70 (0.68)

1.07 (0.79)

0.94 (0.98)

0.01 e

1.07 (0.94)

1.23 (1.27)

1.33 (0.62)

0.06e

23.13 (25.17)

14.79 (34.01)

7.41 (19.58)

0.01 e

30.69 (24.69)

36.23 (20.30)

31.18 (31.97)

0.66e

Lifetime alcoholb , median (IQR)

NOTE: Column percent totals may not sum to 100% due to rounding; Bolded p-values indicated statistical significance; T1-T3 = 1st tertile through 3rd tertile
IQR, interquartile range; SD, Standard Deviation.
a

Quercetin-rich foods: summary measure of apples, grapes, onions, artichoke/fennel/celery, beans, apricots, plums, turnips, peppers, strawberries, tomatoes, and broccoli.

b

Frequency (food groups, servings/day; alcohol, grams/day)

c

ANOVA test.

d

Chi-square test.

e

Non-parametric Kruskal-Wallis test.

f

Total vegetables intake: summary measure of tomatoes, peppers, carrots, salad, peas, beans/chickpeas, mushrooms, broccoli, turnips, savoy, black cabbage, onions, cooked spinach/Swiss
Total fruits intake: summary measure of apples, pears, bananas, kiwis, oranges/grapefruits, mandarins/clementines, grapes, peaches/clingstones, apricots, plums, strawberries, melons, and fruit
cocktails.
g

h

Total meat intake: summary measure of cooked ham (prosciutto cotto), smoked ham (prosciutto crudo), cured ham (speck), salami, baloney (mortadella), wurstel, salted sliced beef, coppa, pancetta,
and other types of processed meats.
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Table 2. MiRs that significantly (at P <0.05) differentiate highest (T3) versus lowest (T1)
consumers of quercetin-rich food intake, separately by histology
T1 mean

T3 mean

Fold Change

p-value

hsa-miR-502

1.089

1.224

1.124

0.0169

hsa-mir-564

1.76

1.566

0.89

0.0297

hsa-miR-124a

1.261

1.074

0.852

0.0440

hsa-miR-125a

1.869

2.813

1.505

0.0450

hsa-miR-510

1.327

1.158

0.872

0.0026

hsa-mir-605

8.312

3.591

0.432

0.0040

hsa-miR-155

0.006

0.008

1.399

0.0122

hsa-miR-373

0.995

0.913

0.917

0.0142

hsa-miR-453

1.817

1.635

0.899

0.0166

hsa-miR-502

1.374

1.1

0.801

0.0172

hsa-miR-18b

0.073

0.108

1.483

0.0197

hsa-miR-183

3.189

2.179

0.683

0.0215

hsa-mir-573

1.306

1.134

0.869

0.0243

hsa-miR-524

1.077

0.921

0.855

0.0358

hsa-mir-612

0.843

0.901

1.069

0.0420

hsa-miR-363

0.927

1.132

1.222

0.0464

Adenocarcinoma (n=97)

Squamous Cell Carcinoma (n=78)

Adjusted for age, sex, BM I, smoking status, non-quercetin-rich fruits and vegetables, red/processed meat, alcohol, and
cigarette packyears
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Table 3: Influence of quercetin-rich food intake (T3-vs-T1) on individual miR, stratified by histology and smoking status
Adenocarcinoma
miR name

Former smokers (n=44)
Fold Change

P -value*

miR name

Current smokers (n=42)
Fold Change

P -value*

hsa-mir-641

0.8280

0.0029

hsa-mir-580

0.7670

0.0028

hsa-miR-29b

1.0920

0.0033

hsa-miR-215

0.7660

0.0039

hsa-miR-146a

0.8900

0.0058

hsa-miR-194

0.6480

0.0107

hsa-miR-500

0.8390

0.0077

hsa-mir-598

0.5740

0.0157

hsa-let-7e

1.2700

0.0175

hsa-miR-518a-2

0.9290

0.0197

hsa-miR-134

0.9520

0.0196

hsa-miR-503

0.6770

0.0369

hsa-miR-26b

2.0030

0.0214

hsa-miR-146b

1.4970

0.0430

hsa-miR-302c

1.1470

0.0229

hsa-miR-381

0.8430

0.0471

hsa-miR-98

1.0060

0.0238

hsa-let-7c

1.0920

0.0241

hsa-miR-27a

1.2900

0.0254

hsa-let-7a

1.4640

0.0259

hsa-let-7g

0.8930

0.0262

hsa-let-7i

1.4090

0.0279

hsa-let-7f

1.3770

0.0303

hsa-miR-195

0.9660

0.0311

hsa-miR-16

1.4290

0.0316

hsa-miR-146b

1.0390

0.0337

hsa-miR-26a

1.7830

0.0343

has-miR-19b

0.7640

0.0361

hsa-mir-564

0.9410

0.0366

hsa-miR-20a

1.0610

0.0411

hsa-miR-106a

1.0470

0.0439

hsa-miR-34a

1.1240

0.0455

hsa-miR-92

1.1210

0.0481

Squamous cell carcinoma
Former smokers (n=38)

Current smokers (n=40)

miR name

Fold Change

P -value*

miR name

Fold Change

P -value*

hsa-miR-492

1.129

0.0115

hsa-miR-502

0.782

0.0103

hsa-miR-510

0.785

0.0212

hsa-mir-605

0.335

0.0127

hsa-miR-491

1.165

0.0227

hsa-miR-506

0.644

0.0166

hsa-mir-612

1.168

0.0252

hsa-miR-183

0.397

0.0282

hsa-miR-500

0.908

0.0284

hsa-miR-524

0.768

0.0294

hsa-mir-663

1.054

0.0341

hsa-miR-503

0.923

0.0344

hsa-miR-453

0.903

0.0348

hsa-mir-654

1.137

0.0411

hsa-mir-658

0.916

0.0467

Note: miRs are ordered by P-value within strata
*Coefficient P-value from ANOVA model adjusted for age, sex, BM I, smoking status, non-quercetin-rich fruits and vegetables, red/processed meat,
alcohol, and cigarette packyears.
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Table 4. Influence of quercetin-rich food intake (T3-vs-T1) on family of functional miR, stratified by
histology and smoking status
Adenocarcinoma

Family
Function
Let-7 family
Tumor suppressor

Squamous Cell Carcinomas

miRNA members

Former
P- value*

Current
P- value*

Former
P- value*

Current
P- value*

hsa-miR-let-7a

P <0.001

P =0.426

P =0.366

P =0.988

hsa-miR-146a
hsa-miR-146b

P =0.002

P =0.092

P =0.753

P =0.222

hsa-miR-26a

P =0.010

P =0.623

P =0.588

P =0.664

P =0.031

P =0.943

P =0.766

P =0.283

P =0.064

P =0.373

P =0.886

P =0.137

P =0.705

P =0.220

P =0.156

P =0.392

P =0.142

P =0.649

P =0.275

P =0.568

P =0.072

P =0.991

P =0.608

P =0.103

P =0.286

P =0.073

P =0.307

P =0.763

hsa-miR-let-7b
hsa-miR-let-7c
hsa-miR-let-7d
hsa-miR-let-7e
hsa-miR-let-7f
hsa-miR-let-7g
hsa-miR-let-7i
hsa-miR-98
hsa-miR-202

miR-146 family
Tumor growth and invasion
miR-26 family
Apoptosis

hsa-miR-26b

miR-17 family

hsa-miR-20a

Tumor progression

hsa-miR-20b
hsa-miR-106a
hsa-miR-106b
hsa-miR-17-5p
hsa-miR-93

miR-29 family
DNA methylation

hsa-miR-29a
hsa-miR-29b
hsa-miR-29c

miR-18 family
Tumor progression
miR-34 family
Tumor suppressor
miR-19 family
Tumor progression
miR-15/16 family
Apoptosis

hsa-miR-18a
hsa-miR-18b
hsa-miR-34a
hsa-miR-34c
hsa-miR-19a
hsa-miR-19b
hsa-miR-503
hsa-miR-15a
hsa-miR-16
hsa-miR-195
hsa-miR-424

NOTE: Only results of miR families that had at least one miR that were significant at p-value <0.05 from individual-based miR
analyses (Table 2); Bolded p-values indicated results that remained significant after Bonferroni correction for multiple
comparisons
M odels adjusted for age, sex, BM I, smoking status, non-quercetin-rich fruits and vegetables, red/processed meat, alcohol, and
cigarette packyears.
a

Refer to Supplemental Table S5 for more detailed functions

*p-value based on Functional Class Score as described in the M ethods section
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Figure 1. Mean expression levels for significant miR groups comparing the highest versus lowest tertile of quercetin-rich food intake in former
smokers with adenocarcinoma
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